Evaluation of an alternative S100b assay for use in cardiac surgery: relationship with microemboli and neuropsychological outcome

Abstract

Introduction. The aim of the study was to investigate the relationship between S100b release, neuropsychological outcome and cerebral microemboli. Peri-operative assay of the astroglial cell protein S100b has been used as a marker of cerebral damage after cardiac surgery but potential assay cross-reactivity has limited its specificity. The present study uses an alternative enzyme-linked immunoabsorbant assay (ELISA) for serum S100b that has documented sensitivity and specificity data in patients undergoing coronary artery bypass grafting (CABG). Methods. Fifty-five consecutive patients undergoing routine CABG surgery received serial venous S100b sampling at five time points: i) Pre-operative, ii) At the end of cardiopulmonary bypass (CPB), iii) 6 hrs, iv) 24 hrs and v) 48 hrs post skin closure. A previously described sandwich ELISA with monoclonal anti- S100b was used. This assay has a lower limit of detection of 0.04 μ g/L and < 0.006% reactivity with S100a at a concentration of 100 μg/L S100a. Cerebral microemboli during surgery were recorded by transcranial Doppler monitor over the right middle cerebral artery. Evidence of cerebral impairment was obtained by comparing patients' performance in a neuropsychological battery of 9 tests administered 6—8 weeks post-operatively with their pre-operative scores. Results. There was a significant increase in S100b only at the end of bypass (mean 0.30 μg/L, SD ± 0.33 and range .00 to 1.57). S100b levels at the end of bypass did not correlate with neuropsychological outcome or microemboli counts. Conclusions. The low levels of S100b detected using the present assay, despite its high sensitivity and despite the routine use of cardiotomy suction, suggest that the assay may have higher specificity for cerebral S100b than previously used assays. There was no evidence that this assay is related to neuropsychological change or cerebral microemboli in cardiac surgery. Perfusion (2007) 22, 267—272.

Get full access to this article

View all access options for this article.

References

Newman S. , Stygall J. Changes in cognition following cardiac surgery. Heart 1999; 82: 541—42.

Ali MS , Harmer M. , Vaughan R. Serum S100 protein as a marker of cerebral damage during cardiac surgery. Br J Anaesth 2000; 85: 287—98.

Vaage J. , Anderson R. Biochemical markers of neurologic injury in cardiac surgery: the rise and fall of S100beta. J Thorac Cardiovasc Surg 2001; 122: 853—5.

Georgiadis D. , Berger A. , Kowatschev E. , et al. Predictive value of S-100beta and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery. J Thorac Cardiovasc Surg 2000; 119: 138—47.

Kilminster S. , Treasure T. , McMillan T. , Holt DW Neuropsychological change and S-100 protein release in 130 unselected patients undergoing cardiac surgery. Stroke 1999; 30: 1869—74.

Westaby S. , Saatvedt K. , White S. et al. Is there a relationship between serum S-100beta protein and neuropsychologic dysfunction after cardiopulmonary bypass? J Thorac Cardiovasc Surg 2000; 119: 132—37.

Pisa EK Serum S-100 protein in stroke and cardiac surgery. Stroke 1999; 30: 1153—54.

Zimmer DB , Cornwall EH , Landar A. , Song W. The S100 protein family: history, function, and expression. Brain Res Bull 1995; 37: 417—29.

Fazio V. , Bhudia SK , Marchi N. , Aumayr B. , Janigro D.

Peripheral detection of S100beta during cardiothoracic surgery: what are we really measuring?

Ann Thorac Surg 2004; 78: 46—52; discussion 52—43.

10.

Jonsson H. , Johnsson P. , Alling C. , Backstrom M. , Bergh C. , Blomquist S. S100beta after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg 1999; 68: 2202—08.

11.

Petzold A. , Keir G. , Lim D. , Smith M. , Thompson EJ Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Res Bull 2003; 61: 281—85.

12.

Green AJ , Keir G. , Thompson EJ A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid . J Immunol Methods 1997; 205: 35—41.

13.

Whitaker DC , Newman SP , Stygall J. , Hope-Wynne C. , Harrison MJ , Walesby RK The effect of leucocyte-depleting arterial line filters on cerebral microemboli and neuropsychological outcome following coronary artery bypass surgery. Eur J Cardiothorac Surg 2004; 25: 267—74.

14.

Ringelstein EB , Droste DW , Babikian VL et al. Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke 1998; 29: 725—29.

15.

Kong RS , Butterworth J. , Aveling W. et al. Clinical trial of the neuroprotectant clomethiazole in coronary artery bypass graft surgery: a randomized controlled trial. Anesthesiology 2002; 97: 585—91.

16.

Anderson RE , Hansson LO , Vaage J. Release of S100B during coronary artery bypass grafting is reduced by off-pump surgery. Ann Thorac Surg 1999; 67: 1721—25.

17.

Steed L. , Kong R. , Stygall J. et al. The role of apolipoprotein E in cognitive decline after cardiac operation. Ann Thorac Surg 2001; 71: 823—26.

18.

Arrowsmith JE , Harrison MJ , Newman SP , Stygall J. , Timberlake N. , Pugsley WB Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke 1998; 29: 2357—62.

19.

Van Dijk D. , Jansen EW , Hijman R. et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. Jama 2002; 287: 1405—12.

20.

Selnes OA , Grega MA , Borowicz LM, Jr. , Royall RM , McKhann GM , Baumgartner WA Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls. Ann Thorac Surg 2003; 75: 1377—84; discussion 1384—86.

21.

Stygall J. , Newman SP , Fitzgerald G. et al. Cognitive change 5 years after coronary artery bypass surgery . Health Psychol 2003; 22: 579—86.

22.

Selnes OA , Royall RM , Grega MA , Borowicz LM, Jr. , Quaskey S. , McKhann GM

Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline?

Arch Neurol 2001 ; 58: 598—604.

23.

Whitaker D. The use of Z scores in assessing neuropsychological change after cardiac operations. Ann Thorac Surg 2003; 75: 1066; author reply 1066—67.

24.

Anderson RE , Hansson LO , Liska J. , Settergren G. , Vaage J. The effect of cardiotomy suction on the brain injury marker S100beta after cardiopulmonary bypass. Ann Thorac Surg 2000; 69: 847—50.